PRORevvity Inc
stock155.61
+1.43 (+0.93%)
Price as of 13 Oct, 11:56 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Strong
Strong investment profile
Technical Analysis
Short-Term Outlook
Bullish
2 bull · 1 bear · 2 neutral
Medium-Term Outlook
Bullish
3 bull · 1 bear · 0 neutral
Price above 50-day MA
Price above 200-day MA
Price above 12-day EMA
Price above 26-day EMA
Neutral momentum zone
MACD below signal line
%K above %D
Price near middle band
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
+1.43
Market Cap
12288309000
Exchange
NYSE
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Revvity Inc
What is Revvity Inc?
Revvity Inc. is a global life sciences and diagnostics company that provides technology, software, and services to pharmaceutical, biotech, and academic organizations. They focus on accelerating scientific discovery and improving patient outcomes by delivering innovative solutions for drug development and laboratory testing. Essentially, they provide the essential tools that researchers and clinicians use to identify diseases and create new medical treatments.
Is Revvity Inc a good investment?
On the positive side, Revvity holds a strong position in the growing diagnostics and life sciences market with a diversified product portfolio. However, investors should be aware that the company faces significant competition and is sensitive to shifts in global healthcare spending and research budgets. Please note that this information is for educational purposes only and does not constitute financial or investment advice.
How do you invest in Revvity Inc?
To invest in Revvity, you can purchase shares directly through a regulated brokerage platform by searching for the ticker symbol RVTY. Alternatively, you may gain indirect exposure to the company by investing in healthcare-focused ETFs or mutual funds that include Revvity in their underlying holdings.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for RVTY — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 16 Sept 2026Targets
No active targets — trend is consolidating.
Famous Investors Holding RVTY
Ken Griffin
1.02M sh · 0.0% of portfolio
$113.92M
NEW
Ken Griffin
433.4K sh · 0.0% of portfolio
$48.22M
NEW
Ray Dalio
24.2K sh · 0.0% of portfolio
$2.69M
NEW
Ken Griffin
23.4K sh · 0.0% of portfolio
$2.60M
NEW
Ken Fisher
12.3K sh · 0.0% of portfolio
$1.37M
NEW
Ken Griffin
7.4K sh · 0.0% of portfolio
$823.3K
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.